TREVENA INC(TRVN)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $0.00 – $1.14
- YTD
- +10566.67%
- IV Rank (30D)
- 0
- Straddle Price
- $2.40
- P/C Vol Ratio
- 0.00
- Exchange
- OTC Link
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +8.54% | 13 |
| Feb | -4.50% | 13 |
| Mar | -6.74% | 13 |
| Apr | -7.26% | 13 |
| May | -0.74% | 13 |
| Jun | -5.39% | 13 |
| Jul | +1.59% | 12 |
| Aug | -7.86% | 12 |
| Sep | -2.35% | 12 |
| Oct | -18.81% | 12 |
| Nov | -7.28% | 12 |
| Dec | -6.58% | 12 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-08 | Pre-Market | 1474.39% | 8.33% | 0.01x | Within |
| 2024-11-07 | Pre-Market | 138.57% | 21.71% | 0.16x | Within |
- IV Rank (30D)
- 0
- IV Rank (7D)
- 0
- Avg IV
- 0.0%
- Straddle (30D)
- $2.40
- Straddle (7D)
- $2.40
- P/C Volume
- 0.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- -336.82
- Correlation (SPY)
- -11.0%
- R²
- 0.01
- Ann. Volatility
- 32821.3%
- SPY Volatility
- 10.7%
Negative beta - stock moves opposite to market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2024-09-17 | Robert T Yoder | SVP, Chief Business Officer | Tax (F) | −487 | $5.95 | -$2.9K | EDGAR |
| 2024-09-17 | Barry Shin | SVP, CFO | Tax (F) | −3 | $5.95 | -$18 | EDGAR |
| 2024-06-17 | Scott Braunstein | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2024-06-14 | Anne M. Phillips | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2024-06-14 | MARK CORRIGAN | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2024-06-14 | Marvin Johnson | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2024-06-14 | Barbara Yanni | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2024-06-14 | Jason Raleigh Nunn | Director | Grant (A) | +13,700 opt | — | EDGAR | |
| 2023-12-15 | Patricia M. Drake | SVP, Chief Commercial Officer | Mixed | +73,165 | $0.61 | $44.6K | EDGAR |
| 2023-12-15 | Barry Shin | SVP, CFO | Mixed | +231,384 | $0.61 | $141.1K | EDGAR |
| 2023-12-15 | Mark Demitrack | SVP, Chief Medical Officer | Mixed | +231,407 | $0.61 | $141.2K | EDGAR |
| 2023-12-15 | Carrie L. Bourdow | President & CEO | Mixed | +462,877 | $0.61 | $282.4K | EDGAR |
| 2023-12-15 | Robert T Yoder | SVP, Chief Business Officer | Mixed | +115,571 | $0.61 | $70.5K | EDGAR |
| 2023-12-05 | Robert T Yoder | SVP, Chief Business Officer | Tax (F) | −3,106 | $0.59 | -$1.8K | EDGAR |
| 2023-12-05 | Mark Demitrack | SVP, Chief Medical Officer | Tax (F) | −5,211 | $0.59 | -$3.1K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | New Enterprise Associates 12, Limited Partnership | 10%+ Owner | 4,811,691 | $53.4K | $40.00M | 1 | 2014-12-10 |
| 2 | FARAH CHAMPSI | Director | 4,390,262 | $48.7K | $10.00M | 1 | 2014-12-10 |
| 3 | RYAN D DRANT | 10%+ Owner | 3,339,281 | $37.1K | $33.07M | 1 | 2014-02-07 |
| 4 | FOREST LABORATORIES INC | 10%+ Owner | 2,964,895 | $32.9K | $12.00M | 1 | 2014-02-07 |
| 5 | JOHN W LITTLECHILD | 10%+ Owner | 2,149,193 | $23.9K | $16.64M | 1 | 2014-02-07 |
| 6 | GUY P NOHRA | 10%+ Owner | 967,741 | $10.7K | $16.53M | 1 | 2014-02-07 |
| 7 | Carrie L. Bourdow | President & CEO | 642,923 | $7.1K | $117.9K | 26 | 2023-12-15 |
| 8 | Scott Applebaum | CLCO; SVP, Regulatory Affairs | 344,022 | $3.8K | $0 | 3 | 2021-02-12 |
| 9 | Mark Demitrack | SVP, Chief Medical Officer | 309,817 | $3.4K | $0 | 16 | 2023-12-15 |
| 10 | MAXINE GOWEN | President & CEO | 270,500 | $3.0K | $291.5K | 17 | 2020-05-15 |
| 11 | LEON O JR MOULDER | Director | 150,000 | $1.7K | $302.0K | 11 | 2023-06-20 |
| 12 | John P. Hamill | VP Fin,Princ Fin&Acct Officer | 87,750 | $974 | $8.7K | 3 | 2019-06-04 |
| 13 | Patricia M. Drake | SVP, Chief Commercial Officer | 83,913 | $931 | $0 | 8 | 2023-12-15 |
| 14 | Michael W. Lark | Sr. VP, Research & CSO | 74,761 | $830 | -$169.6K | 8 | 2017-08-29 |
| 15 | Polaris Venture Partners Founders' Fund V, L.P. | 10%+ Owner | 71,575 | $794 | -$244.2K | 1 | 2014-08-15 |
| 16 | Polaris Venture Partners V, L.P. | 10%+ Owner | 36,369 | $404 | $21.60M | 2 | 2014-08-18 |
| 17 | Rosamond Deegan | Sr VP, Bus Dev & Operations | 31,105 | $345 | -$308 | 3 | 2014-10-01 |
| 18 | Roberto Cuca | Sr. VP and CFO | 25,000 | $278 | $100.0K | 8 | 2018-03-02 |
| 19 | Barry Shin | SVP, CFO | 12,349 | $137 | -$13.0K | 20 | 2024-09-17 |
| 20 | John M Limongelli | Sr. VP,General Counsel & CAO | 12,000 | $133 | $48.4K | 8 | 2018-03-02 |
| 21 | MICHAEL R DOUGHERTY | Director | 7,000 | $78 | $28.0K | 10 | 2023-06-20 |
| 22 | Robert T Yoder | SVP, Chief Business Officer | 5,868 | $65 | $0 | 17 | 2024-09-17 |
| 23 | Jason Raleigh Nunn | Director | 4,271 | $47 | $0 | 11 | 2024-06-14 |
| 24 | David Soergel | Sr. VP,Clinical Dev. & CMO | 1,750 | $19 | -$275.2K | 8 | 2017-03-03 |
| 25 | Barbara Yanni | Director | 1,250 | $14 | $5.0K | 12 | 2024-06-14 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.